| Line Item | 2026-03-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $510K | +5000.0% | -64.1% |
| Cost of Revenue | $290K | -43.2% | -27.9% |
| Gross Profit | $584K | -26.0% | -42.7% |
| R&D Expense | $1.5M | +71.3% | +84.7% |
| SG&A Expense | $626K | -25.8% | -46.3% |
| Operating Income | -$12.7M | -907.0% | -701.8% |
| Net Income | -$12.7M | -934.9% | -744.3% |
| EPS (Basic) | -$0.60 | -900.0% | -757.1% |
| EPS (Diluted) | -$0.60 | -900.0% | -757.1% |
| Line Item | 2026-03-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $2.2M | -35.6% | -69.5% |
| Accounts Receivable | $662K | +17.9% | +1.5% |
| Current Assets | $3.5M | -27.8% | -60.6% |
| Total Assets | $3.8M | -76.6% | -81.5% |
| Current Liabilities | $1.0M | +43.9% | -70.4% |
| Total Liabilities | $1.0M |
| Line Item | 2026-03-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.5M | — | -2572.2% |
| Capital Expenditures | $17K | — | — |
| Investing Cash Flow | -$1.3M | — | — |
| Financing Cash Flow | $110K | — | — |
| Free Cash Flow | -$3.5M | — | — |
| -70.2% |
| Stockholders' Equity | $2.7M | -82.3% | -83.8% |